The Subjective Experiences of Ceasing Regular, Low-Dose, Sustained-Release Morphine when Treating Moderate to Severe Chronic Breathlessness
Introduction: Using time-limited trials of low-dose, sustained-release morphine to reduce chronic breathlessness to evaluate net effects may generate opioid withdrawal symptoms if medication is ceased. This sub-study of a larger randomized, placebo-controlled, double-blind trial aimed to evaluate if this occurred. Methods: People with modified Medical Research Council breathlessness scores of 3 or
